Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -57.35% | 188.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -57.35% | 188.17% | |||
| Cost of Revenue | -49.50% | 148.58% | |||
| Gross Profit | -60.21% | 205.86% | |||
| SG&A Expenses | -55.12% | 105.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -51.06% | 114.58% | |||
| Operating Income | -18.49% | 43.87% | |||
| Income Before Tax | 72.38% | -31.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 72.38% | -31.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 72.38% | -31.59% | |||
| EBIT | -18.49% | 43.87% | |||
| EBITDA | 13.87% | 43.87% | |||
| EPS Basic | 75.00% | -33.33% | |||
| Normalized Basic EPS | 80.00% | -25.00% | |||
| EPS Diluted | 75.00% | -33.33% | |||
| Normalized Diluted EPS | 80.00% | -25.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||